卒中患者心脏康复的成本效果分析
本研究采用马尔可夫模型,在30年时间跨度内比较心脏康复与常规照护对轻残缺血性卒中患者的成本效果。结果显示心脏康复为优势策略,增量效果为3.28质量调整生命年,增量成本为5704美元,增量成本效果比为1740美元/质量调整生命年。双向敏感性分析未改变结果,心脏康复仍为最优策略。
要点
- 心脏康复较常规照护可增加3.28质量调整生命年。
- 增量成本为5704美元,增量成本效果比为1740美元/质量调整生命年。
- 敏感性分析显示心脏康复始终为最优策略。
核心结论
- 心脏康复在轻残缺血性卒中患者中具有成本效果,为优势策略。
研究设计与样本
- 采用马尔可夫模型,时间跨度为30年,周期长度为1年。
- 模型输入参数基于近期已发表文献。
- 健康状态以改良Rankin量表评分的残疾程度定义。
- 成本基于近期成本效果分析,并按美国消费者价格指数医疗保健组分调整为2024年美元。
- 研究对象为轻残缺血性卒中患者,场景为门诊环境。
主要发现
- 心脏康复较常规照护增量效果为3.28质量调整生命年,增量成本为5704美元。
- 增量成本效果比为1740美元/质量调整生命年。
- 对上述变量进行双向敏感性分析未改变结果,心脏康复仍为最优策略。
关键数值与推荐
- 增量成本效果比为1740美元/质量调整生命年(心脏康复 vs 常规照护)。
- 增量效果为3.28质量调整生命年,增量成本为5704美元。
临床怎么用
- 对于轻残缺血性卒中患者,可考虑将心脏康复作为具有成本效果的康复策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the cost-effectiveness of a cardiac rehabilitation program in individuals with stroke compared with customary care. DESIGN: A Markov model was created using a 30-year time horizon, with cycle lengths of 1 year to determine the effectiveness and cost-effectiveness of a cardiac rehabilitation program in persons with stroke. Input parameters were based on recently published literature. Health states were defined as degree of disability evaluated by the modified Rankin scale score. Costs were based on recent cost-effectiveness analyses and inflated to 2024 US Dollars using the medical care component of the US Consumer Price Index. SETTING: Outpatient ambulatory setting. PARTICIPANTS: Persons with mild disability after ischemic stroke. INTERVENTION: A model comparing cardiac rehabilitation versus usual care was created. MAIN MEASURES: Quality-adjusted life years (QALYs) were used to measure the effectiveness of cardiac rehabilitation versus usual care. The cost-effectiveness of cardiac rehabilitation versus usual care was compared with respect to incremental costs, incremental effectiveness, and incremental cost-effectiveness ratios (ICERs). RESULTS: Cardiac rehabilitation was the superior strategy, resulting in higher incremental effectiveness of 3.28 QALY at an increased incremental cost of $5704. The ICER was $1740/QALY. A two-way sensitivity analysis of these variables had no change, with cardiac rehab remaining the optimal strategy. CONCLUSIONS: While numerous studies and systematic analyses have reported compelling evidence of the clinical benefits of cardiac rehabilitation for patients with stroke, the current study contributes to the existing body of literature, demonstrating that cardiac rehabilitation is also cost-effective in the stroke population.
引用
- Ruff J, Udeh B, Linder S, et al. Cardiac Rehabilitation for Persons with Stroke: A Cost-Effectiveness Analysis. Clin Rehabil. 2025. PMID: 39748671. doi:10.1177/02692155241302765
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。